Birlinn® DPYD Control P112
Assess assay performance and support consistent DPYD variant detection with MMQCI’s NEW Birlinn® DPYD Control P112. Covering 23 relevant DPYD variants, including all AMP Tier 1 and Tier 2 recommended variants, this control features defined homozygous, heterozygous, and wild-type (WT) genotypes to help laboratories maintain quality assurance across pharmacogenomic testing workflows.
VeriDose Core Control Panel
Expand pharmacogenomic quality assurance with MMQCI’s NEW VeriDose Core Control Panel (P116), covering 85 recommended SNPs/INDELs across 16 key genes implicated in drug metabolism pathways. Its broad genetic coverage provides laboratories with a valuable tool for assessing multi-gene pharmacogenomic assay performance.
NAT2 & TPMT/NUDT15
Controls Coming Soon